NuGenomics
PrivateLast Round
Early Funding
Oct 5, 2023
Total Funding Raised
$500,000
Momentum
Top 10%
of companies Caplight tracks
Company Overview
NuGenomics is a health-tech company that provides DNA-based genetic testing and personalized wellness plans for weight management, diabetes, and longevity.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Healthcare Analytics, Biotechnology, Sports & Fitness
Business Model
B2C
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NuGenomics Comparables
Compare NuGenomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Unlock.fit | 91% | |
| Gena HealthX | 83% | |
| Lifecode Genorex Pvt. Ltd. | 82% |
NuGenomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Oct 5, 2023 | ||||
| Accelerator | Jun 21, 2021 |
Key People
Founding team and executive leadership
NuGenomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| India Accelerator | Accelerator |
| Inflection Point Ventures | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Grew 27% QoQ from 11 to 14 employees.
- Apr 18, 2026
Monthly visitors grew 469% MoM, reaching 16.7K.
NuGenomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NuGenomics's valuation, stock price, and market status.
Is NuGenomics a public or private company?
NuGenomics is a private company.
What is the current stock price of NuGenomics?
NuGenomics is a private company with no public stock price. No recent secondary market data is available.
How much is NuGenomics worth (valuation)?
Valuation information for NuGenomics is not publicly available.
Can I buy NuGenomics stock?
NuGenomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was NuGenomics's last funding round?
NuGenomics's most recent funding round was Early Funding on October 5, 2023.
Who are the main investors in NuGenomics?
Key investors in NuGenomics include India Accelerator, Inflection Point Ventures.
Will NuGenomics IPO soon?
No public IPO plans have been announced for NuGenomics.
How can I track NuGenomics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NuGenomics's secondary market activity and sign up for updates.